These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1721613)

  • 1. Differential effects of the immunosuppressive macrolides FK-506 and rapamycin on activation-induced T-cell apoptosis.
    Staruch MJ; Sigal NH; Dumont FJ
    Int J Immunopharmacol; 1991; 13(6):677-85. PubMed ID: 1721613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.
    Dumont FJ; Staruch MJ; Koprak SL; Melino MR; Sigal NH
    J Immunol; 1990 Jan; 144(1):251-8. PubMed ID: 1688572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells.
    Dumont FJ; Melino MR; Staruch MJ; Koprak SL; Fischer PA; Sigal NH
    J Immunol; 1990 Feb; 144(4):1418-24. PubMed ID: 1689353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative and temporal analysis of the cellular interaction of FK-506 and rapamycin in T-lymphocytes.
    Dumont FJ; Kastner C; Iacovone F; Fischer PA
    J Pharmacol Exp Ther; 1994 Jan; 268(1):32-41. PubMed ID: 7507994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin inhibits IL-1-mediated interferon-gamma production in the YAC-1 T cell lymphoma.
    Altmeyer A; Dumont FJ
    Cytokine; 1993 Mar; 5(2):133-43. PubMed ID: 7687472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK-520 and rapamycin.
    Teutsch M; Higer M; Wang D; Wortis HW
    Int Immunol; 1995 Mar; 7(3):381-92. PubMed ID: 7540861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunosuppressive macrolides FK-506 and rapamycin.
    Thomson AW
    Immunol Lett; 1991 Jul; 29(1-2):105-11. PubMed ID: 1717376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK-506, and rapamycin.
    Duncan JI
    J Invest Dermatol; 1994 Jan; 102(1):84-8. PubMed ID: 7507155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.
    Dumont FJ; Staruch MJ; Koprak SL; Siekierka JJ; Lin CS; Harrison R; Sewell T; Kindt VM; Beattie TR; Wyvratt M
    J Exp Med; 1992 Sep; 176(3):751-60. PubMed ID: 1380976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells.
    Cho CS; Chang Z; Elkahwaji J; Scheunemann TL; Manthei ER; Colburn M; Knechtle SJ; Hamawy MM
    Int Immunol; 2003 Nov; 15(11):1369-78. PubMed ID: 14565935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction.
    Sigal NH; Dumont FJ
    Annu Rev Immunol; 1992; 10():519-60. PubMed ID: 1375473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A.
    Fruman DA; Klee CB; Bierer BE; Burakoff SJ
    Proc Natl Acad Sci U S A; 1992 May; 89(9):3686-90. PubMed ID: 1373887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation.
    Bierer BE; Schreiber SL; Burakoff SJ
    Eur J Immunol; 1991 Feb; 21(2):439-45. PubMed ID: 1705513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin and FK506 differentially inhibit mast cell cytokine production and cytokine-induced proliferation and act as reciprocal antagonists.
    Hatfield SM; Mynderse JS; Roehm NW
    J Pharmacol Exp Ther; 1992 Jun; 261(3):970-6. PubMed ID: 1376361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of immunosuppressive drugs on the regulation of activation-induced apoptotic cell death in thymocytes.
    McCarthy SA; Cacchione RN; Mainwaring MS; Cairns JS
    Transplantation; 1992 Sep; 54(3):543-7. PubMed ID: 1384186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unexpected up-regulation of gene expression by cyclosporin A and FK-506 in a T-cell lymphoma: both immunosuppressants augment Ly-6E antigen induction by interferon-gamma in the presence of ionomycin.
    Altmeyer A; Staruch MJ; Fischer PA; Durette PL; Tocci MJ; Sigal NH; Dumont FJ
    Int J Immunopharmacol; 1991; 13(8):1187-99. PubMed ID: 1726093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FK 506 and rapamycin: molecular probes of T-lymphocyte activation.
    Bierer BE; Jin YJ; Fruman DA; Calvo V; Burakoff SJ
    Transplant Proc; 1991 Dec; 23(6):2850-5. PubMed ID: 1721296
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin.
    Zeevi A; Woan M; Yao GZ; Venkataramanan R; Todo S; Starzl TE; Duquesnoy RJ
    Transplant Proc; 1991 Dec; 23(6):2928-30. PubMed ID: 1721315
    [No Abstract]   [Full Text] [Related]  

  • 19. FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells.
    de Paulis A; Cirillo R; Ciccarelli A; Condorelli M; Marone G
    J Immunol; 1991 Apr; 146(7):2374-81. PubMed ID: 1706398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FK-506 and rapamycin but not cyclosporin inhibit aldosterone-stimulated sodium transport in A6 cells.
    Rokaw MD; West ME; Palevsky PM; Johnson JP
    Am J Physiol; 1996 Jul; 271(1 Pt 1):C194-202. PubMed ID: 8760046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.